Sonnet BioTherapeutics Holdings, Inc. (SONN)

NASDAQ: SONN · IEX Real-Time Price · USD
0.280
+0.004 (1.60%)
Jun 24, 2022 4:00 PM EDT - Market closed

Stock Price Forecast

According to 8 stock analysts, the average 12-month stock price forecast for SONN stock is $2.3, which predicts an increase of 721.43%. The lowest target is $2.02 and the highest is $2.63. On average, analysts rate SONN stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $2.02 $2.3 $2.3 $2.63
Change +621.43% +721.43% +721.43% +839.29%

Analyst Ratings

The average analyst rating for SONN stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 333333
Buy 555544
Hold 111111
Sell 000000
Strong Sell 000000
Total 999988

Financial Forecast

Revenue This Year
204.00K
Decreased by -57.82%
Revenue Next Year
n/a
EPS This Year
-0.47
EPS Next Year
-0.40
Year 2017201820192020202120222023202420252026
Revenue
41.43M30.73M--483.63K204.00K----
Revenue Growth
-0.65%
-25.82%
---
-57.82%
----
EPS
-70.98-51.48-0.91-6.96-1.02-0.47-0.40-0.51-0.47-0.44
EPS Growth
----------
No. Analysts -----44422

Revenue Forecast

Revenue 20222023202420252026
High 210,000 n/a n/a n/a n/a
Avg 204,000 n/a n/a n/a n/a
Low 196,000 n/a n/a n/a n/a

Revenue Growth

Revenue Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -

EPS Forecast

EPS 20222023202420252026
High -0.45 -0.26 -0.53 -0.49 -0.46
Avg -0.47 -0.40 -0.51 -0.47 -0.44
Low -0.49 -0.53 -0.49 -0.46 -0.43

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -